(Q39986329)

16 September 2017

title

Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer (English)

1 reference

16 September 2017

1 reference

16 September 2017

1 reference

16 September 2017

1 reference

16 September 2017

Aedín C Culhane

0 references

Darran P O'Connor

0 references

Karin Jirstrom

1 reference

16 September 2017

Donal J Brennan

1 reference

16 September 2017

Elton Rexhepaj

1 reference

16 September 2017

Sallyann L O'Brien

1 reference

16 September 2017

Elaine McSherry

1 reference

16 September 2017

Ailís Fagan

1 reference

16 September 2017

Robert C Millikan

1 reference

16 September 2017

Goran Landberg

1 reference

16 September 2017

Michael J Duffy

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

16 September 2017

published in

Clinical Cancer Research

1 reference

16 September 2017

1 reference

16 September 2017

1 reference

16 September 2017

page(s)

2681-2689

1 reference

Expression of survivin and its relationship to loss of apoptosis in breast carcinomas

16 September 2017

cites work

1 reference

12 December 2020

Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1.

1 reference

12 December 2020

Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer.

1 reference

12 December 2020

Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer

1 reference

12 December 2020

Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function

1 reference

12 December 2020

Telomerase activity in relation to p53 status and clinico-pathological parameters in breast cancer

1 reference

12 December 2020

Prognostic importance of survivin in breast cancer

1 reference

12 December 2020

p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer

1 reference

12 December 2020

Immunohistochemical analysis of survivin expression in primary breast cancers.

1 reference

12 December 2020

The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

1 reference

12 December 2020

The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly

1 reference

12 December 2020

Nuclear export is essential for the tumor-promoting activity of survivin.

1 reference

12 December 2020

ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis

1 reference

12 December 2020

Global histone modification patterns predict risk of prostate cancer recurrence

1 reference

12 December 2020

Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer

1 reference

12 December 2020

Analysis of human transcriptomes.

1 reference

12 December 2020

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

12 December 2020

CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

1 reference

12 December 2020

Infrared spectroscopic imaging for histopathologic recognition

1 reference

12 December 2020

Novel c-MYC target genes mediate differential effects on cell proliferation and migration

1 reference

12 December 2020

Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation

1 reference

12 December 2020

The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function

1 reference

12 December 2020

High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer

1 reference

12 December 2020

Control of apoptosis and mitotic spindle checkpoint by survivin

1 reference

12 December 2020

Survivin: a promising tumor biomarker

1 reference

12 December 2020

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

12 December 2020

Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients

1 reference

12 December 2020

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

12 December 2020

Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response

1 reference

12 December 2020

Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma

1 reference

12 December 2020

CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer

1 reference

12 December 2020

Survivin's dual role: an export's view

1 reference

12 December 2020

Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle

1 reference

12 December 2020

Nuclear or cytoplasmic expression of survivin: what is the significance?

1 reference

12 December 2020

Separating the anti-apoptotic and mitotic roles of survivin

1 reference

12 December 2020

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

12 December 2020

Survivin is an independent prognostic marker for risk stratification of breast cancer patients

1 reference

12 December 2020

10.1158/1078-0432.CCR-07-1760

Identifiers

DOI

1 reference

16 September 2017

0 references

1 reference